Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: Results of a comparative study

Annals of Surgery

Volumn 242, Issue 6, 2005, Pages 767-773

  Bassi, Claudio ^a   Falconi, Massimo ^a   Molinari, Enrico ^a   Salvia, Roberto ^a   Butturini, Giovanni ^a   Sartori, Nora ^a   Mantovani, William ^a   Pederzoli, Paolo ^a   Russell, ^b   Buchler ^b   Brennan, ^b   Jeekel, ^b   Jaeck, ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BILE DUCT FISTULA; CLINICAL TRIAL; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROSTOMY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PANCREAS FISTULA; PANCREAS RESECTION; PANCREATICOGASTROSTOMY; PANCREATICOJEJUNOSTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; SURGICAL MORTALITY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; FEMALE; GASTROSTOMY; HUMANS; INCIDENCE; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PANCREATICOJEJUNOSTOMY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 28344457829     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000189124.47589.6d     Document Type: Conference Paper

References (32)

1. Alexakis N, Halloran C, Raraty C, et al. Current standard of surgery for pancreatic cancer. Br J Surg. 2004;91:1410-1427.
2. Sakorafas GH, Friess H, Balsiger BM, et al. Problems of reconstruction during pancreatoduodenectomy. Dig Surg. 2001;18:363-369.
3. Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg. 200;232:419-429.
4. Buchler M, Friess H, Klempa I, et al. Role of octreotide in the prevention of postoperative complications of elective pancreatic resection. Am J Surg. 1992;163:125-131.
5. Pederzoli P, Bassi C, Falconi M, et al. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery: Italian Study Group. Br J Surg. 1994;81:265-269.
6. Montorsi M, Zago M, Mosca F, et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery. 1995;117:26-31.
7. Friess H, Beger HG, Sulkowski U, et al. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg. 1995;82:1270-1273.
8. Lowy AM, Lee JE, Pisters PW, et al. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg. 1997;226:632-641.
9. Gouillat C, Chipponi J, Baulieux J, et al. Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy. Br J Surg. 2001;88:1456-1462.
10. Sarr MG for the Pancreatic Surgery Group. The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial. J Am Coll Surg. 2003;196:556-565.
11. Sue B, Msika S, Piccinini M, et al. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial. Arch Surg. 2004;139:288-294.
12. Yeo C, Cameron J, Maher M, et al. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg. 1995;222:580-588.
13. Reissman P, Perry J, Cuenca A, et al. Pancreaticojejunostomy versus controlled pancreaticocutaneous fistula in pancreaticoduodenectomy for periampullary carcinoma. Am J Surg. 1995;169:585-588.
14. Tran K, Van Eijck C, Di Carlo V, et al. Occlusion of the pancreatic duct versus pancreaticojejunostomy: a prospective randomized trial. Ann Surg. 2002;236:422-428.
15. Strasberg SM, Debrin JA, Mokadam NA, et al. Prospective trial of a blood supply-based technique of pancreaticojejunostomy: effect on anastomotic failure in the Whipple procedure. J Am Coll Surg. 2002;194:746-758.
16. Bassi C, Falconi M, Molinari E, et al. Duct-to-mucosa versus end-to-side pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: results of a prospective randomized trial. Surgery. 2003;134:766-771.
17. Sue B, Msika S, Fingerhut A, et al. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection: prospective randomized trial. Ann Surg. 2003;237:57-65.
18. Lillemoe KD, Cameron JL, Kim MP, et al. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg. 2004;8:766-764.
19. Schlitt HJ, Schmidt U, Simunec D, et al. Morbidity and mortality associated with pancreatogastrostomy and pancreatojejunostomy following partial pancreatoduodenectomy. Br J Surg2E 2002;89:1245-1251.
20. Fabre JM, Arnaud JP, Navarro F, et al. Results of pancreatogastrostomy after pancreaticoduodenectomy in 160 consecutive patients. Br J Surg. 1998;85:751-754.
21. Hyodo M, Nagai H. Pancreatogastrostomy after pancreatoduodenectomy with or without duct-to-mucosa anastomosis for the small pancreatic duct: short and long term results. Hepatogastroenterology. 2002;47:1138-1141.
22. Kim SW, Youk EG, Park YH, et al. Comparison of pancreaticogastrostomy and pancreaticojejunostomy after pancreaticoduodenectomy performed by one surgeon. World J Surg. 1997;21:640-643.
23. Takano S, Ito Y, Watanabe Y, et al. Pancreaticojejunostomy versus pancreaticogastrostomy in reconstruction following pancreaticoduodenectomy. Br J Surg. 2000;87:423-427.
24. Oussoultzoglou E, Bachellier P, Bogourdan JM, et al. Pancreaticogastrostomy decreased relaparotomy caused by pancreatic fistula after pancreaticoduodenectomy compared with pancreaticojejunostomy. Arch Surg. 2004;139:327-335.
25. Bassi C, Falconi M, Salvia R, et al. Management of complications after pancreaticoduodenectomy in a high volume centre: results on 150 consecutive patients. Dig Surg. 2001;18:453-457.
26. Bartoli FG, Arnone GB, Ravera G, et al. Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy: review and statistical meta-analysis regarding 15 years of literature. Anticancer Res. 1991;11:1831-1148.
27. Friess H, Malfertheiner P, Isenmann R, et al. The risk of pancreaticointestinal anastomosis can be predicted preoperatively. Pancreas. 1996;13:202-208.
28. Al-sharaf K, Ihse I, Dawiskiba S, et al. Characteristic of the gland remnant predict complications after subtotal pancreatectomy. Dig Surg. 1997;14:101-106.
29. Hamanaka Y, Nishihara K, Hamasaki T, et al. Pancreatic juice output after pancreatoduodenectomy in relation to pancreatic consistency, duct size, and leakage. Surgery. 1996;119:281-287.
30. Van Geen RC, Gouma DJ. Impact of hospital volume on in-hospital mortality in pancreatic surgery. Surg Technol Int. 2002;10:61-65.
31. Saettler EB, Temple WJ. The surgeon as a prognostic factor in the management of pancreatic cancer. Surg Oncol Clin North Am. 2000;9:133-142.
32. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128-1137.